Weekly taxane administration — the dose-dense scheduling of paclitaxel (80 mg/m² weekly) and docetaxel (30-35 mg/m² weekly) demonstrating superior efficacy in certain indications while reducing peak toxicity — creating the practice pattern evolution reshaping oncology infusion center operations, with the Taxane Market tracking weekly scheduling as the patient-centric and...